Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,156,900
+$610,977 QoQ
Shares Held
2,632
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#2,079
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VeraBank, N.A. holds $15,922,408 across 9 Drug Manufacturers - General names. LLY ranks #3 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,786 | $3,755,200 | |
| 2 | ABBV |
AbbVie Inc.
|
14,486 | $3,645,256 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
2,632 | $3,156,900 | |
| 4 | AMGN |
Amgen Inc
|
4,636 | $1,678,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,222 | $1,313,526 | |
| 6 | GSK |
GSK plc
|
20,501 | $1,074,662 | |
| 7 | PFE |
Pfizer Inc
|
28,634 | $689,506 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,797 | $353,372 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,156,900 | 2,632 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,545,923 | 2,768 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,243,384 | 3,018 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,356,907 | 3,089 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,407,968 | 3,089 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,427,349 | 2,939 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,847,908 | 3,689 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,247,856 | 3,666 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,321,839 | 3,669 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,862,114 | 3,679 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,229,669 | 3,825 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,012,626 | 3,747 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,724,439 | 3,677 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,262,755 | 3,677 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,356,900 | 3,709 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,199,305 | 3,709 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $1,202,569 | 3,709 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,071,882 | 3,743 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,044,664 | 3,782 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $819,303 | 3,546 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $793,680 | 3,458 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $635,188 | 3,400 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $574,056 | 3,400 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $503,268 | 3,400 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $558,212 | 3,400 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $471,648 | 3,400 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||